LY4298445

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY4298445, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA) [Phase 1]

See pricing